Alto Neuroscience, Inc. APIC, Share-based Payment Arrangement, Recognition and Exercise
Alto Neuroscience, Inc. (ANRO) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of -$190.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2026-08-12
- Alto Neuroscience, Inc. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2026-03-31 was -$190.00K.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month |
|---|---|
| 2026-03-31 | -$190.00K 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |